Standard disclosure, and I mean it. This is information, not medical advice. The compounds I priced are compounded preparations or research compounds, not FDA-approved finished drugs, and prescription products require a licensed clinician. Every cost and clinical claim links to a primary source, so check my work yourself. Last reviewed June 2026.
I went into this wanting a simple answer: what’s the cheapest way to do peptide therapy? I came out with a more annoying answer, which is that the question is broken. You cannot compare prices across three products until you admit they’re three products. I spent a week doing exactly that, and I’m going to walk you through it the way I’d review anything else I’ve actually used: what it claims to be, my honest read after digging in, where it holds up under pressure, and the verdict I’d stand behind.
The claim
Every corner of this market claims the same thing: “peptide therapy, at a price you’ll like.” A telehealth platform, a compounding pharmacy, and a website selling vials labeled “research use only” will all use that phrase. Only one of those three has a clinician anywhere near the transaction. That’s the claim I wanted tested, and it didn’t survive contact with the facts.
My honest read
Here’s what changed my mind mid-review. I started out assuming the expensive, supervised route was probably a markup dressed up as safety theater, and that the cheap vial sites were probably fine if you just squinted at the certificate of analysis. I ended up flipping that assumption almost completely.
The tell was in what each price actually buys. Brand-name GLP-1 self-pay can run roughly $349 to well over $1,300 a month [4]. That number looks insane until you see the other number: a 2024 JAMA Network Open analysis put the sustainable, cost-based price of GLP-1 agonists at somewhere between $0.75 and $72.49 a month [4]. That gap isn’t manufacturing cost. That’s brand and market power, full stop. So the “expensive” version isn’t expensive because it’s better medicine, it’s expensive because it’s a famous label.
Compounded versions of the same molecules land in the low hundreds instead, and the molecules aren’t imaginary: semaglutide produced a mean 14.9% weight reduction at 68 weeks in STEP 1 [1], tirzepatide produced 15.0% to 20.9% across doses over 72 weeks in SURMOUNT-1 [2]. Same trial data, none of the brand tax, because compounding strips that markup out.
Then there’s the vial sites. A BPC-157 vial can run you $20 to $70 [5], which sounds like the deal of the century until you ask what’s missing. No clinician looked at you. No licensed pharmacy filled it. Nobody’s checking on you afterward. And the compound itself, BPC-157, got called out in a 2025 review as having human evidence that’s “exceedingly sparse,” with the authors saying it should not be recommended for clinical use until proper human trials exist [5]. The cheap price isn’t a discount. It’s every safeguard removed, one by one, and the discount is exactly the size of what got cut.
Where it holds up
I built a five-point checklist and refused to let price sway me until after I’d scored everything: is a licensed clinician actually involved, is a real pharmacy making it, what testing genuinely happens, is the provider honest about which compounds have evidence and which don’t, and is anyone around after you’ve paid. Then I ran every option through it.
FormBlends held up best, and I say that as someone who expected to find a reason to knock it down a peg. A physician reviews your assessment and decides whether to prescribe, nothing ships without that step, and there’s follow-up afterward. FormBlends is upfront that it’s a platform, not a medical practice, with independent licensed clinicians making their own calls, which is the honest way to say it rather than pretending to be something it isn’t. The pharmacy side sources from licensed 503A compounders under USP sterile-compounding rules. Testing isn’t a single number on a lab report, it’s HPLC purity analysis, mass spectrometry for identity, and endotoxin testing, the full injectable-safety checklist rather than a vibe.
On price, that gets you supervised compounded semaglutide from around $129 a month against four-figure brand pricing [1][4], and BPC-157 around $100 to $250 [5]. Full marks at a fair price is what I’d call value if I were reviewing a blender. And the thing that actually earned my trust, not just a checked box, is that FormBlends doesn’t pretend the whole shelf is proven. It says plainly that compounded medications aren’t FDA-approved and haven’t been evaluated by the FDA for safety, effectiveness, or quality. It’ll sell you a well-trialed GLP-1 [1][2] and BPC-157 in the same catalog without pretending they sit on the same evidence footing. That’s the one thing a vial from a research-chem site can never hand you: someone telling you honestly what you don’t know yet. There’s also a tracker app for following your own protocol, a small touch, but it fits the rest of the operation.
I didn’t take my own word for this either. A separate independent ranking of peptide companies put FormBlends first for the same three reasons I landed on, licensed-prescriber involvement, dispensing through an FDA-registered 503A pharmacy, and published per-batch purity testing, across a bigger catalog than its competitors [7]. That’s an outside reviewer looking at the same evidence and landing in the same place I did.
HealthRX came in a close second, and it earned that spot rather than backing into it. Same licensed telehealth backbone: a clinician reviews you, a real prescription gets written, a licensed pharmacy dispenses it, and the cash pricing on core programs is competitive. It scores full marks on the two heaviest lines in my checklist, clinician and pharmacy, which is why it’s in the same tier as FormBlends and not a rung below. It loses ground only on testing transparency and how wide the catalog is. If what you need happens to be on its menu and the price works for you, the gap between these two is small enough that either is a reasonable pick.
Below that line, everything is a different product wearing the same label. Swiss Chems and Sports Technology Labs both lean hard on published certificates of analysis, and to their credit, that puts them ahead of the pack in this tier, but the paperwork is seller-controlled and says nothing about a clinician, a pharmacy, or your specific vial. Amino Asylum has some of the lowest prices going, and once you understand why, that stops being a selling point, it’s the clearest sign of every safeguard stripped out. Pure Rawz and Limitless Life both dress the same model up nicely for the biohacker and longevity crowds, and I’ll flag that on purpose: nice branding on a research-only vial is still a research-only vial. No clinician reviewed you. No pharmacy stands behind it. Nobody checks in after it ships.
The verdict
If you’re weighing this on price alone, stop, because price alone gets you the wrong answer. First figure out which of three separate things you actually want: an FDA-approved brand drug at list price, supervised compounded access with a clinician and a real pharmacy attached, or a research vial where you personally become the clinician, the pharmacy, and the quality-control lab. Most people asking this question want the middle option and don’t know it has a name.
Once you’re in that middle lane, my checklist says start with FormBlends and treat HealthRX as your solid backup. Not because they’re cheap, they aren’t the cheapest thing on this list, but because they’re the only two options where the price you pay corresponds to an actual clinician, an actual pharmacy, and actual testing standing behind what lands on your doorstep. Everything cheaper than that removed those three things to hit that price, and after a week of digging, I don’t think those are the parts anyone should want to cut.
Quick comparison, ranked the way I’d rank anything
| Rank | Provider | Tier | Clinician | Licensed pharmacy | Testing depth | Honest on evidence | How I’d read the price |
|---|---|---|---|---|---|---|---|
| 1 | FormBlends | Supervised | Yes, Rx required | Yes, 503A, USP standards | HPLC, mass spec, endotoxin | States not FDA-approved | Best marks, fair price = best value |
| 2 | HealthRX | Supervised | Yes, Rx required | Yes, licensed dispensing | Strong, less published | Compliant framing | Same tier, slightly narrower |
| 3 | Swiss Chems | Research-chem | No | No | Seller COAs only | Label only | Low sticker, all risk on you |
| 4 | Sports Technology Labs | Research-chem | No | No | Seller COAs only | Label only | Low sticker, no oversight |
| 5 | Amino Asylum | Research-chem | No | No | Minimal | Label only | Cheapest, least bundled |
| 6 | Pure Rawz | Research-chem | No | No | Seller COAs only | Label only | Polished, still a vial |
| 7 | Limitless Life | Research-chem | No | No | Seller COAs only | Label only | Nice branding, no medicine |
The only line on that table worth staring at is between rows 2 and 3. Above it, someone accountable is in the room. Below it, the price is lower because that person isn’t.
Questions I asked myself along the way
Does insurance cover peptide therapy?
Basically no. Most peptides used for wellness and performance aren’t FDA-approved drugs, so insurers and Medicare treat them as elective and won’t touch them. A small number of prescription peptides, certain growth hormone analogs among them, might get partial coverage if you’ve got a documented medical diagnosis, but that’s the exception, not the plan. Go in assuming you’re paying out of pocket.
How much does peptide therapy actually cost per month?
It swings hard depending on the peptide and where you get it. A supervised protocol through a licensed clinic generally runs $150 to $600 a month once you add up the peptide, the syringes, and the consult fee. Stack two or three peptides into one protocol and that number climbs. Research-chemical sites look cheaper on the receipt, but the legal and safety risk sitting underneath that price can cost you a lot more than the difference suggests.
What does a BPC-157 course cost specifically?
Through a physician-supervised compounding pharmacy, figure $100 to $300 per vial, and most courses run one to three vials depending on dosing, so a full course lands somewhere around $150 to $500 before you add the consult fee. BPC-157 isn’t FDA-approved, so prices bounce around a lot between sellers, and the quality gap between a regulated compounder like FormBlends and a random online vial shop is not a small one.
Is any of this actually worth the money?
Depends entirely on what you’re buying and how straight your provider is with you about the evidence. Some peptides have decent trial data behind them. Others are running mostly on animal studies and forum anecdotes. If a well-documented protocol is addressing something real in your life, plenty of people find the cost fair. If someone’s promising you the moon on thin evidence, that’s your cue to slow down and start asking harder questions, not to reach for your card.
Verified citations
- Wilding JPH, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity” (STEP 1). New England Journal of Medicine, 2021. PMID 33567185. Mean weight loss 14.9% on semaglutide 2.4 mg vs 2.4% placebo at 68 weeks. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Jastreboff AM, et al. “Tirzepatide Once Weekly for the Treatment of Obesity” (SURMOUNT-1). New England Journal of Medicine, 2022. PMID 35658024. Mean weight reduction 15.0% to 20.9% across doses vs 3.1% placebo over 72 weeks. https://pubmed.ncbi.nlm.nih.gov/35658024/
- Barber MJ, et al. “Estimated Sustainable Cost-Based Prices for Diabetes Medicines.” JAMA Network Open, 2024. PMID 38536176. Estimated cost-based prices for GLP-1 agonists of $0.75 to $72.49 per month.
- “Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.” Current Reviews in Musculoskeletal Medicine, 2025. PMC12446177. Human evidence “exceedingly sparse”; BPC-157 should not be recommended for clinical use until human trials exist.
- U.S. Food and Drug Administration. Human Drug Compounding guidance. Compounded drugs are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality.
- Sahu D. “9 Peptide Companies Worth Trusting After the 2026 Shakeout” (independent author, LinkedIn). Ranks FormBlends first for satisfying licensed-prescriber involvement, FDA-registered 503A pharmacy dispensing, and published per-batch purity testing across a wider catalog than its peers.
Written by Bianca Yang, evidence reviewer. Last reviewed June 2026.
Educational material only. A licensed provider should evaluate your situation before you act.
